The consistent growth
partner of choice

22

In Business

6

In operation

630

Completed

3

Committed

Growth Debt Pioneer

Since 1998, Kreos Capital has committed in excess of €3.1bn across +630 transactions, to more than 450 pan-European and Israeli high-growth companies in the technology and healthcare sectors. Today, we invest more than €400m a year and continue to enhance our product offering and presence in the market.

Throughout this time, Kreos Capital has been the consistent growth partner of choice, providing clarity and continuity for both management teams and equity sponsors looking for a long-term finance partner.

Broad Geographical Reach Across Europe & Israel

Since pioneering our investment strategy more than 22 years ago, Kreos Capital has grown to become the leading growth debt provider in our target regions, with broad coverage and transaction history across Europe and Israel. In fact, Kreos Capital is now the only lender that can offer both local support and international coverage having invested in 17 countries and across a wide array of sectors.

Flexible, tailored approach

At Kreos Capital, we understand that true innovation requires adaptable and responsive financing. With significant financial backing from blue-chip institutional investors, robust infrastructure, and large, experienced investment team, Kreos consistently provides debt facilities that match the ever evolving needs of high-growth companies.

Support for every stage

Kreos Capital has the experience and resources to support high-growth companies through every stage of their growth life cycle, from entry-level growth, mid-stage development, through to late stage & pre-IPO / exit funding, as well as publicly listed growth funding.

Extensive experience & investment history in Technology & Healthcare

Kreos Capital provides financing for companies across the wide spectrum of the Technology and Healthcare sectors. In Technology, we have invested across fintech, enterprise software, cybersecurity, semiconductors, digital marketing, AI and other sub-sectors, while in Healthcare, we have backed companies in areas such as drug & treatment development, medical products & devices, and healthcare tech.

Software

Software

Deeptech

Deeptech

Fintech

Fintech

Digital

Digital

Life Science

Life Science

Successful track record

Kreos Capital has built its reputation through an unwavering support for all of our portfolio companies during multiple business cycles, including the most recent impacts of COVID-19. Through these tough times, we can rely on our close and mutually beneficial working relationships with both our equity sponsor partners and management teams, and they can rely on us. That is why we are widely recognised throughout the industry as the preferred choice when partners are really needed.